TP53 and cancer: In almost all cancers, six ‘hotspot’ residues are frequently mutated in the TP53 DBD, namely R175 (4.8%), G245 (3.12%), R248 (6.79%), R249 (2.59%), R273 (6.55%), and R282 (2.59%) (IARC TP53 Database) [77].